ResearcherUniversity of VeronaNo recent work listed
Giuliano Barugola
Matched on ORCID iD 0000-0002-0995-8683; OpenAlex author ID A5011826870. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2011: 1 paper · 2012: 3 papers · 2013: 1 paper
Papers 5
- Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. Co-author DOI 10.1111/hpb.12073↗
- Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Co-author DOI 10.1016/j.amjsurg.2011.03.008↗
- Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. Co-author DOI 10.1016/j.dld.2012.05.017↗
- Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? Co-author DOI 10.1016/j.surg.2012.05.017↗
- Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Co-author DOI 10.1245/s10434-011-1769-1↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stefano Partelli · 5 shared papers, 2011–2013 · strength 0.16
- Paper Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. DOI 10.1111/hpb.12073↗
- Paper Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. DOI 10.1016/j.amjsurg.2011.03.008↗
- Paper Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. DOI 10.1016/j.dld.2012.05.017↗
- Massimo Falconi · 5 shared papers, 2011–2013 · strength 0.16
- Paper Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. DOI 10.1111/hpb.12073↗
- Paper Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. DOI 10.1016/j.amjsurg.2011.03.008↗
- Paper Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. DOI 10.1016/j.dld.2012.05.017↗
- Stefano Crippa · 5 shared papers, 2011–2013 · strength 0.16
- Paper Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. DOI 10.1111/hpb.12073↗
- Paper Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. DOI 10.1016/j.amjsurg.2011.03.008↗
- Paper Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. DOI 10.1016/j.dld.2012.05.017↗
- Paolo Pederzoli · 4 shared papers, 2011–2013 · strength 0.13
- Paper Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. DOI 10.1111/hpb.12073↗
- Paper Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. DOI 10.1016/j.amjsurg.2011.03.008↗
- Paper Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? DOI 10.1016/j.surg.2012.05.017↗
- Claudio Bassi · 3 shared papers, 2012–2013 · strength 0.10
- Paper Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. DOI 10.1111/hpb.12073↗
- Paper Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. DOI 10.1016/j.dld.2012.05.017↗
- Paper Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? DOI 10.1016/j.surg.2012.05.017↗
- Mirko D’Onofrio · 3 shared papers, 2011–2012 · strength 0.09
- Paper Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. DOI 10.1016/j.amjsurg.2011.03.008↗
- Paper Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. DOI 10.1016/j.dld.2012.05.017↗
- Paper Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient sel… DOI 10.1245/s10434-011-1769-1↗
- Paola Capelli · 3 shared papers, 2011–2012 · strength 0.09
- Paper Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. DOI 10.1016/j.amjsurg.2011.03.008↗
- Paper Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? DOI 10.1016/j.surg.2012.05.017↗
- Paper Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient sel… DOI 10.1245/s10434-011-1769-1↗
- Giovanni Butturini · 1 shared paper, 2013 · strength 0.04
- Roberto Salvia · 1 shared paper, 2013 · strength 0.04
- Domenico Tamburrino · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.